Finally, as TET2-associated gene expression at RP defines a subset of cases with significantly worse prognosis in the tested cohorts, the biological role of TET2 in high-risk PCa could also be examined further through in vitro studies to determine whether knockdown or induction of these genes is associated with motility or proliferation in prostate cancer cells. Here, TET2 is linked to posterior cortical atrophy.